2024-03-29T13:09:06Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_45EF032BD7EE
2024-03-23T02:18:33Z
serval:BIB_45EF032BD7EE
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.
10.1016/j.thromres.2011.06.031
21840043
000301587400045
Asmis
L.M.
author
Alberio
L.
author
Angelillo-Scherrer
A.
author
Korte
W.
author
Mendez
A.
author
Reber
G.
author
Seifert
B.
author
Stricker
H.
author
Tsakiris
D.A.
author
Wuillemin
W.A.
author
article
2012
Thrombosis Research
1879-2472
0049-3848
journal
129
4
492-498
Adult
Anticoagulants/blood
Artifacts
Blood Coagulation Tests/methods
Drug Monitoring/methods
Factor Xa/antagonists & inhibitors
Humans
Male
Morpholines/blood
Reproducibility of Results
Sensitivity and Specificity
Switzerland
Thiophenes/blood
eng
60_published
peer-reviewed
Publication types: Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish